Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

60275 1492790397HCLSReviewGreeceApril2017.pdf
Energy Boardroom

UPDATED: Allergan spurns Valeant again, but shareholders may have other ideas

10.06.2014 / Fierce Pharma

Valeant may have raised its offer–twice–since Allergan spurned its first takeover proposal, but the Botox maker is still singing the same tune. Allergan's board has unanimously shot down Valeant once again, claiming its sweetened bid still undervalues the company. Valeant, however, won't take the rejection lying down.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: